(Washington, D.C.) —Testifying before the House Judiciary Subcommittee on Regulatory Reform, Commercial and Antitrust Law, Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt offered policy recommendations to help stem the rising tide of drug abuse and reduce costs at the hearing, Treating the Opioid Epidemic: the State of Competition in the Markets for Addiction Medicine.
“We commend Congress for passing the Comprehensive Addiction and Recovery Act (CARA). This new law will help stop ‘drugstore shopping’ by allowing Medicare Part D plans to restrict known abusers to select pharmacies for certain medications, such as opioids,” said PCMA President and CEO Mark Merritt.
Merritt also encouraged policymakers to consider the following recommendations:
- Prescribers should be required to use e-prescribing for all controlled substances.
- State governments should improve their Prescription Drug Management Program (PDMP) databases to be more accessible, accurate in real-time, and integrated across the country.
- Medicare Part D plans should be allowed to suspend payments of suspicious claims, consistent with the rest of Medicare.